1. Home
  2. CPIX vs RNXT Comparison

CPIX vs RNXT Comparison

Compare CPIX & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$2.57

Market Cap

34.1M

Sector

Health Care

ML Signal

HOLD

Logo RenovoRx Inc.

RNXT

RenovoRx Inc.

HOLD

Current Price

$0.95

Market Cap

36.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPIX
RNXT
Founded
1999
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.1M
36.4M
IPO Year
2009
2021

Fundamental Metrics

Financial Performance
Metric
CPIX
RNXT
Price
$2.57
$0.95
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.75
AVG Volume (30 Days)
92.6K
295.1K
Earning Date
11-04-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$41,278,349.00
$928,000.00
Revenue This Year
N/A
$2,795.35
Revenue Next Year
N/A
$272.69
P/E Ratio
N/A
N/A
Revenue Growth
12.21
N/A
52 Week Low
$1.85
$0.70
52 Week High
$7.25
$1.69

Technical Indicators

Market Signals
Indicator
CPIX
RNXT
Relative Strength Index (RSI) 56.08 51.82
Support Level $2.11 $0.92
Resistance Level $2.73 $0.93
Average True Range (ATR) 0.23 0.05
MACD 0.08 0.02
Stochastic Oscillator 72.60 81.94

Price Performance

Historical Comparison
CPIX
RNXT

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

Share on Social Networks: